Tobacco Products

Cigarette Packaging and Advertising Compliance Update – Impact of Ongoing Litigation

February 2012

Due to ongoing litigation, the implementation of The Food and Drug Administration’s (FDA) final rule entitled “Required Warnings for Cigarette Packages and Advertisements” is uncertain. Anyone who manufactures, packages, or imports for sale or distribution cigarettes within the United States, and any manufacturer or importer who advertises or causes to be advertised cigarettes within the United States, must continue to comply with the requirements for cigarette health warnings under the Federal Cigarette Labeling and Advertising Act, 15 U.S.C. §§ 1331-1340 (“FCLAA”), as in effect before amendment by the Family Smoking Prevention and Tobacco Control Act.  Pending further notice, the Federal Trade Commission (FTC) will continue to have responsibility for the review and approval of cigarette warning plans under the existing FCLAA requirements, and all questions regarding the submission, review, or approval of such plans should be addressed to FTC. 


 

Contact FDA

1-877-287-1373
(9am EST-4pm EST)
Tobacco

For General Inquiries:
AskCTP@fda.hhs.gov


Center for Tobacco Products
Food and Drug Administration
10903 New Hampshire Avenue
Document Control Center

Building 71, Room G335
Silver Spring, MD 20993-002


Courier Deliveries

Page Last Updated: 03/30/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English